JWH-359
 | |
| Identifiers | |
|---|---|
| |
| ChemSpider | 35303437 |
| Chemical and physical data | |
| Formula | C24H36O2 |
| Molar mass | 356.540 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| (verify) | |
JWH-359 is a dibenzopyran "classical" cannabinoid drug, which is a potent and selective CB2 receptor agonist, with a Ki of 13.0nM and selectivity of around 220x for CB2 over CB1 receptors. It is related to other dibenzopyran CB2 agonists such as JWH-133 and L-759,656 but with a chiral side chain which has made it useful in mapping the shape of the CB2 binding site.[1][2] It was discovered by, and named after, Dr. John W. Huffman.
References
- ↑ Huffman, J.; Bushell, S.; Joshi, S.; Wiley, J.; Martin, B. (2006). "Enantioselective synthesis of 1-methoxy- and 1-deoxy-2'-methyl-delta8-tetrahydrocannabinols: new selective ligands for the CB2 receptor". Bioorganic & Medicinal Chemistry. 14 (1): 247–262. doi:10.1016/j.bmc.2005.08.013. PMID 16165365.
- ↑ "Recent advances in the development of selective ligands for the cannabinoid CB(2) receptor". Curr Top Med Chem. 8 (3): 187–204. 2008. doi:10.2174/156802608783498014. PMID 18289088.
This article is issued from Wikipedia - version of the 10/14/2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.